Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 36.04
+1.50 (4.34%)
Aug 11, 2026, 1:14 PM HKT
HKG:3692 Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, HKG:3692 stock has a consensus rating of "Strong Buy" and an average price target of $46.53. The average 1-year stock price forecast is 29.11% higher than the current stock price, while the lowest is $37.37 (+3.69%) and the highest is $53.05 (+47.20%).
Price Target: $46.53 (+29.11%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:3692 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 19 | 18 | 18 | 16 | 16 | 16 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 25 | 25 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +24.86% | Jul 29, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $42.00 | Buy | Maintains | $42.00 | +16.54% | Jul 26, 2026 |
Unknown Analyst Nomura No rating | Nomura | Hold Maintains $37.24 | Hold | Maintains | $37.24 | +3.33% | Jul 24, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $44.68 | Buy | Maintains | $44.68 | +23.97% | Jul 16, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $48.80 | Buy | Maintains | $48.80 | +35.41% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
16.92B
from 15.03B
Increased by 12.57%
Revenue Next Year
18.47B
from 16.92B
Increased by 9.20%
EPS This Year
0.98
from 0.93
Increased by 5.74%
EPS Next Year
1.07
from 0.98
Increased by 8.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.